Cambridge Vision Achieved, AstraZeneca Looks To Realize ‘Pipeline 2’ Ambitions

Analysts Expect Revenues To Double By 2026

 
• By Andrew McConaghie

Having achieved a turnaround in its R&D and commercial fortunes, AstraZeneca’s hopes the opening of a new research center will herald its next wave of novel therapies.

AstraZeneca Cambridge opening
CEO Pascal Soriot at the opening of the new Discovery Centre in Cambridge, with HRH the Prince of Wales, UK business secretary Kwasi Kwarteng and AZ chairman Leif Johansson.. • Source: Getty Images

More from Business

More from Scrip